Coordinated adipose–liver metabolic remodelling reveals sex-specific peripheral adaptations during amyotrophic lateral sclerosis progression in TDP-43A315T mice
This study demonstrates that amyotrophic lateral sclerosis progression in TDP-43A315T mice involves extensive, coordinated metabolic remodelling in peripheral tissues like adipose and liver that exhibits distinct tissue-specific and sex-dependent patterns, suggesting peripheral metabolism contributes to disease heterogeneity and offers potential therapeutic targets.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Amyotrophic lateral sclerosis, often called ALS, is a devastating disease that slowly destroys the nerves controlling voluntary muscles, leaving the body paralyzed while the mind usually remains sharp. For decades, doctors and scientists viewed this condition as a problem confined strictly to the nervous system. However, a growing body of evidence now suggests that ALS is a systemic disorder, meaning it affects the entire body. Patients frequently lose weight rapidly, even when they are eating normally, and their bodies often burn energy at an unusually high rate. This has led researchers to look beyond the brain and spinal cord, investigating whether the body's metabolic engines—specifically the organs that store and process fat and sugar—are malfunctioning and perhaps even contributing to the disease's progression.
In this context, a team of researchers set out to map exactly how the body's fat-storing tissues and the liver change as the disease advances. They focused on a specific genetic model of the disease in mice, which carries a mutation in a protein called TDP-43, a defect found in many human cases of ALS. By examining these mice at different stages of their lives, from before they showed any symptoms to the final stages of the disease, the scientists discovered that the body's metabolic response is not a uniform collapse. Instead, it is a complex, shifting landscape where different organs react in distinct ways, and where male and female bodies respond almost entirely differently to the same disease.
The researchers began by looking at white adipose tissue, the body's main fat storage depot. In the male mice, they found that the chemical makeup of the fat cells began to change long before the animals showed any signs of weakness or paralysis. Using advanced chemical analysis, they observed that the types of fats inside these cells were being rearranged. Early in the disease, the changes involved specific fats that are crucial for the function of mitochondria, the tiny power plants inside cells. As the disease progressed toward the end stage, the fat cells began to accumulate large amounts of stored energy in the form of triglycerides. This suggests that the fat tissue is not just passively wasting away but is actively undergoing a profound chemical reorganization that starts silently and evolves as the disease worsens.
The story was different when the scientists turned their attention to brown adipose tissue, a type of fat that generates heat to keep the body warm. In male mice, this tissue did not show significant changes until the very end of the disease. At that late stage, the fat cells began to express higher levels of genes related to their identity and their ability to handle energy, along with a surge in signals involving leptin, a hormone that helps regulate appetite and energy use. However, the classic markers for heat production remained unchanged. This indicates that the brown fat was not simply turning on its furnace; rather, it was undergoing a late-stage adaptation, perhaps trying to maintain the body's energy balance as the disease took its toll.
Perhaps the most striking discovery was the difference between males and females. While the male mice showed these dramatic changes in their fat tissues, the female mice displayed a completely different pattern of adaptation, one centered in the liver. In female mice at the end stage of the disease, the liver began to act as if it was preparing to burn fat for fuel. The genes responsible for taking up fatty acids from the blood and breaking them down were turned up, while the genes responsible for creating new fat were turned down. Simultaneously, the liver increased production of a specific hormone that helps coordinate energy use across the whole body. This suggests that female mice were mounting a specific defense in their liver to keep their metabolism running efficiently, a strategy that the male mice did not appear to use.
To see if these findings in mice mattered to people, the researchers looked at blood samples from human patients with ALS at the time they were diagnosed. They measured the levels of cholesterol, a key fat molecule in the blood. The results mirrored the sex differences seen in the mice. Male patients tended to have lower cholesterol levels, and this level seemed to shift depending on how quickly their disease progressed, particularly if they had a higher body weight. Female patients, however, showed a different pattern, with cholesterol levels that did not follow the same trend as the men. This confirms that the metabolic differences observed in the lab are real and present in human patients right from the start of their illness.
These findings paint a picture of ALS as a disease that reshapes the entire body's metabolism in a highly specific way. The changes are not random; they are coordinated responses that vary by organ and by sex. The fat tissue in men shows early warning signs of trouble, while the liver in women launches a distinct survival strategy. This research suggests that the body's metabolic organs are active participants in the disease, not just bystanders. By understanding these different pathways, scientists may eventually find new ways to track the disease or develop treatments that support the body's natural attempts to adapt, offering hope for a more personalized approach to care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.